Gerald Illerhaus (G Illerhaus)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 5

Top Venues

Leukemia & lymphoma

BMC cancer

Leukemia

Nature reviews. Disease primers

This page only lists publications with an associated author ORCID identifier.

Publications

Andrés J M Ferreri, Teresa Calimeri, Kate Cwynarski, Jorg Dietrich, Christian Grommes, Khê Hoang-Xuan, Leland S Hu, Gerald Illerhaus, Lakshmi Nayak, Maurilio Ponzoni, Tracy T Batchelor
Primary central nervous system lymphoma. Nature reviews. Disease primers 9 (1) (2023)
J Hammersen, Sebastian Birndt, K Döhner, Philipp Alexander Reuken, A Stallmach, P Sauerbrey, F La Rosée, M Pfirrmann, C Fabisch, M Weiss, K Träger, H Bremer, S Russo, Gerald Illerhaus, D Drömann, S Schneider, Paul La Rosée, Andreas Hochhaus
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial. Leukemia (2023)
Julia Wendler, Christopher P Fox, Elke Valk, Cora Steinheber, Heidi Fricker, Lisa K Isbell, Simone Neumaier, Jessica Okosun, Florian Scherer, Gabriele Ihorst, Kate Cwynarski, Elisabeth Schorb, Gerald Illerhaus
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma. BMC cancer 22 (1) (2022)
Anna Brandt, Jakob Matschke, Wilfried Fehrle, Lisa von Wenserski, Carsten Bokemeyer, Gerald Illerhaus, Mascha Binder
A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells. Leukemia & lymphoma 60 (2) (2018)
Elmar Spies, Michael Fichtner, Fabian Müller, Susanne Krasemann, Gerald Illerhaus, Markus Glatzel, Mascha Binder, Martin Trepel
Comment on "Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins". Journal of immunology (Baltimore, Md. : 1950) 195 (10) (2016)

Gerald Illerhaus.css-eqlu8i{font-size:small;padding-left:4px;} (G Illerhaus)

Publication Activity (10 Years)

Top Topics

Top Venues

Gerald Illerhaus (G Illerhaus)